Novo Nordisk, which has stumbled through a bit of a manufacturing hangover at a former Catalent production site it ...
With a second late-stage trial win for its investigational HIV combo in the books, Gilead Sciences is moving full steam ahead ...
The survey showed that while most of the doctors didn’t have top-of-mind awareness of oral semaglutide’s upcoming FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback